Big Molecule News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PTAB Issues Final Written Decisions Finding Claims Of Recombinant Lentiviral Vector Patents Valid - Patent

PTAB Issues Final Written Decisions Finding Claims Of Recombinant Lentiviral Vector Patents Valid - Patent
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.

Sloan ketteringInstitute for cancer researchCornell universityBluebird bioFinal written decisions finding claimsRecombinant lentiviral vector patents validBig molecule

Moderna Litigation Against BioNTech And Pfizer Stayed Pending IPR - Patent

We previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, "Moderna") against BioNTech SE, BioNTech Manufacturing GmbH.

United statesRichardg stearnsTrademark officeModernatx incPfizer incModerna us incBiontech us incPatent trialAppeal boardUnited states patentJudge richardJudge stearnsModerna litigation againstStayed pendingBig moleculeModerna litigation against biontech and pfizer stayed pending ipr

Post-Trial Updates On Regeneron V Mylan (Aflibercept) BPCIA Litigation - Patent

Appeals from and redacted memorandum and opinion in support of judgment in Regeneron v. Mylan (aflibercept) BPCIA case filed

West virginiaUnited statesSamsung bioepisBiocon biologics incPharmaceuticals incBiocon biologicsNorthern districtBiocon defendantsRemaining patentsBiocon defendantsBig molecule watchPost trial updatesBig molecule

Year in Review: Top Legal Developments of 2023 | Goodwin

As we settle into 2024, we reflect on the significant legal developments of 2023 that hold potential impact on the biologics and biosimilars market. The following is a recap of.

United statesWest virginiaFiasp flextouchJanssen pharmsFiasp penfillNovolog penfillBiocon biologicsSamsung bioepisRichard andrewsNovolog flexpenNational employees health planBoehringer ingelheimCentocor ortho biotech incNovartis pharms corpBristol myers squibbTrustees of the university pennsylvania

Year In Review: Top Deals In 2023 - Life Sciences, Biotechnology & Nanotechnology

According to PWC, "2023 was a reasonably strong year for the pharmaceutical and life sciences sector with both deal value and volume of M&A close to pre-pandemic levels."

United statesUnited kingdomReddy laboratories ltdCo ltdConsortium meetingTonghua dongbao pharmaceutical co ltdCoherus biosciences incSurface oncology incCoya therapeutics incAlteogen incBig moleculeCoya therapeuticsSouth americaAmyotrophic lateralAnnual northeastNanjing king friend biochemical